InvestSMART

Aumake Limited (ASX:AUK)

ALERT: Price-sensitive ASX Announcement for AUK
Current share price for AUK : $0.003 0.001 (50%)+
Announcement
Release
17 Feb 2026 9:21AM
Price at Release
$0.002
Full Release
download
Summary
Aumake Limited has entered into a $10 million exclusive global distribution agreement with EZZ Life Sciences. This strategic partnership, formalized on 17 February 2026, is set for a four-year term with a focus on high-margin nutraceutical products, aiming for minimum annual sales of $2.5 million. The agreement includes exclusive global distribution rights, cooperative manufacturing models, and targets the Chinese market. EZZ will retain full ownership of intellectual property and branding, and failure to meet sales targets could result in termination of the agreement. The collaboration aligns with Aumake's strategy to expand its commercial network, particularly in the Chinese e-commerce and B2B markets.
Key Points
  • Aumake Limited signs $10m exclusive global distribution agreement with EZZ Life Sciences.
  • The agreement is for a four-year term with a minimum annual sales target of $2.5 million.
  • Distribution includes high-margin nutraceutical products like EZZ Glutathione Health Support.
  • Agreement supports Aumake's strategy to expand in the Chinese market.
  • EZZ retains full control over intellectual property and branding.
  • Non-compliance with sales targets results in automatic termination of exclusive rights.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.